))
Biomarker Testing Laws: How Are They Helping?
Manage episode 462960003 series 3482052
Contenido proporcionado por Breastcancer.org. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Breastcancer.org o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
In cancer, biomarkers are features of the tumor, such as a genetic mutation or the presence of a certain protein. These biomarkers affect how the cancer behaves. Doctors use the results of biomarker testing to make treatment recommendations.
Several organizations, including the American Cancer Society and the LUNGevity Foundation, through the No One Missed campaign, are working to pass laws to require insurance coverage for biomarker testing for people with cancer.
Joanna Fawzy Doran, CEO of Triage Cancer, discusses some of the issues people face getting biomarker testing covered by insurance and how the new laws are helping.
Listen to the episode to hear Joanna talk about:
- which biomarker tests are less likely to be covered by insurance
- the insurance plans the laws do and don’t apply to
- the options people have when a health insurance carrier denies coverage for a biomarker test deemed necessary by a doctor
323 episodios
Compartir
